We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

98 hedge funds and large institutions have $1.18B invested in IVERIC bio, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 13

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

54% more capital invested

Capital invested by funds: $768M → $1.18B (+$412M)

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

34% more funds holding

Funds holding: 7398 (+25)

58% less call options, than puts

Call options by funds: $2.34M | Put options by funds: $5.54M

Holders
98
Holders Change
+25
Holders Change %
+34.25%
% of All Funds
2.82%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
39
Increased
38
Reduced
15
Closed
13
Calls
$2.34M
Puts
$5.54M
Net Calls
-$3.2M
Net Calls Change
+$3.12M
Name Holding Trade Value Shares
Change
Change in
Stake
TA
51
Teachers Advisors
New York
$814K +$196K +5,351 +39%
TD Asset Management
52
TD Asset Management
Ontario, Canada
$808K -$36.7K -1,000 -5%
Neuberger Berman Group
53
Neuberger Berman Group
New York
$779K +$675K +18,400 New
State of New Jersey Common Pension Fund D
54
State of New Jersey Common Pension Fund D
New Jersey
$740K +$642K +17,500 New
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$664K +$91.7K +2,500 +19%
JP Morgan Chase
56
JP Morgan Chase
New York
$652K -$176K -4,786 -24%
Swiss National Bank
57
Swiss National Bank
Switzerland
$652K +$565K +15,400 New
SKK
58
Shepherd Kaplan Krochuk
Massachusetts
$631K +$203K +5,532 +59%
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
$616K -$442K -12,054 -45%
Bessemer Group
60
Bessemer Group
New Jersey
$555K +$482K +13,127 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$512K +$444K +12,094 New
RJA
62
Raymond James & Associates
Florida
$492K +$26.1K +710 +7%
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$486K +$422K +11,490 New
Citadel Advisors
64
Citadel Advisors
Florida
$483K +$419K +11,417 New
NFA
65
Nationwide Fund Advisors
Ohio
$451K +$126K +3,436 +48%
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$430K +$373K +10,160 New
MLICM
67
Metropolitan Life Insurance Company (MetLife)
New York
$426K +$12.4K +338 +3%
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$399K +$77.9K +2,123 +29%
AIG
69
American International Group
New York
$384K +$112K +3,050 +51%
ACM
70
Atika Capital Management
New York
$360K +$312K +8,500 New
COPPSERS
71
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$352K +$305K +8,320 New
Two Sigma Investments
72
Two Sigma Investments
New York
$326K -$98.6K -2,686 -26%
VOYA Investment Management
73
VOYA Investment Management
Georgia
$303K +$263K +7,157 New
Group One Trading
74
Group One Trading
Illinois
$292K -$104K -2,823 -29%
ProShare Advisors
75
ProShare Advisors
Maryland
$286K -$101K -2,753 -29%

ISEE Hedge Fund Activity: Q2 2014 in Review

98 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2014, worth a combined $1.18B — up 54% from $768M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ISEE positions and 13 closed out — a net gain of 26 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $68.3M. The largest seller was Clarus Ventures, cutting an estimated $55M.

  • 98 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2014, up from 73 in Q1 2014.
  • Funds reported $1.18B of IVERIC bio, Inc. Common Stock stock for Q2 2014, up 54% quarter-over-quarter.
  • 39 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2014 and 13 closed out, a net change of +26 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2014 was Fidelity Investments, an estimated $68.3M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2014 was Clarus Ventures, an estimated $55M sold.

Based on aggregated 13F filings for Q2 2014.